ACG 2020 Annual Scientific Meeting

Join GI physicians from the U.S. and around the world for the virtual ACG Annual Scientific Meeting. ACG 2021 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

NEW for ACG 2021! We have added an ACG All Access Pass, combine the three ACG Friday courses with the Postgraduate Course and the Annual Meeting plus the two bonus sessions (formerly the Learning Lunches and Breakfast Sessions) and save 20 percent! Register for any two courses and save up to 10 percent!

Monday, October 25, 2021 | 7:50 am - 6:30 pm
7:50 am Opening Remarks
David A. Greenwald, MD, FACG, ACG President
8:00 am Presidential Plenary Session 1
Moderators: David A. Greenwald, MD, FACG, and Brooks D. Cash, MD, FACG
9:00 am President's Address
David A. Greenwald, MD, FACG, ACG President
Introduced by: Samir A. Shah, MD, FACG, ACG President-Elect
9:30 am Presidential Plenary Session 2
Moderators: Samir A. Shah, MD, FACG, and Brooks D. Cash, MD, FACG
10:00 am Exhibit Hall Opens
10:15 am Hands-On Endoscopy Workshop Center Opens
10:30 am Scientific Poster Sessions Open
10:30 am Break – Visit the Exhibit Hall and Browse Scientific Posters
10:30 am Exhibitor Theater
11:30 am Simultaneous Symposia Session 1 – Choose from 3

Symposium 1A: ACG Past Presidents’ Symposium

Moderator: Sunanda V. Kane, MD, MSPH, FACG

  • Intestinal Dysbiosis and Recurrent C. difficile: Impact and Clinical Solutions
    Past President: Christina M. Surawicz, MD, MACG
    Jessica R. Allegretti, MD, MPH

    Discuss and apply emerging therapeutic options for dysbiosis and recurrent C. difficile.
  • New Technologies in GERD and How to Use Them in the Clinical Setting
    Past President: Joel E. Richter, MD, MACG
    Marcelo F. Vela, MD, MSCR, FACG

    Recognize evolving technologies in GERD and how to use them in the clinical setting.
  • Improving Access, Acceptability, Quality, and Cost-Effectiveness of Colon Cancer Screening
    Past President: Mark B. Pochapin, MD, FACG
    John M. Inadomi, MD, FACG

    Appraise and apply contemporary best evidence in the management of colon cancer screening.

Symposium 1B: Complications of Advanced Liver Disease
Moderator: Norah A. Terrault, MD, MPH, FACG

  • Updates in Current Management of Ascites, SBP, and HRS
    Jasmohan S. Bajaj, MD, MSc, FACG
    Discuss best practices in the evaluation of abdominal ascites, spontaneous bacterial peritonitis, and acute kidney injury in patients with liver cirrhosis, and apply current evidence-based guideline recommendations.
  • Update in Liver Transplantation: Implications for the GI Provider
    Norah A. Terrault, MD, MPH, FACG
    Summarize new UNOS policies governing organ allocation for liver transplantation, and outline evidence-based recommendations for the general gastroenterologist caring for patients both pre- and post-transplantation.
  • Current Concepts in the Management of Hepatic Encephalopathy
    R. Todd Frederick, MD
    Review current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.

Symposium 1C: Update on Endoscopic Resection of Colorectal Lesions
Moderator: Tonya R. Kaltenbach, MD, MS, FACG

  • Optical Diagnosis of Benign and Malignant Colorectal Lesions
    Sarah K. McGill, MD
    Identify the signature features of benign and malignant colorectal lesions and apply classifications to enhance real-time histologic prediction of lesions.
  • Cold Snare Polypectomy for Complete Removal of Small Colorectal Lesions
    Swati G. Patel, MD
    Discuss the updated USMSTF recommendations on optimal polypectomy techniques for small colorectal lesions.
  • EMR of Large Colorectal Lesions
    Tonya R. Kaltenbach, MD, MS, FACG
    Describe the techniques for endoscopic mucosal resection of large colon polyps, and identify best practices including when to refer to a specialist.
  • Prevention and Management of Large Polyp Resection Complications
    Douglas K. Rex, MD, MACG
    Identify methods to prevent and manage complications of large polyp resection.
  • Quality and Competency in Colorectal Lesion Removal: Training and Sustaining
    Roy M. Soetikno, MD, FACG
    Summarize competency learning curves and optimal training strategies for colorectal lesion removal, including simulation-based learning.
12:45 pm Lunch Break – Visit the Exhibit Hall and Browse Scientific Posters
12:45 pm ACG – FDA Public Forum
12:45 pm Exhibitor Theater
1:00 pm Scientific Poster Session – Authors Present
1:40 pm Exhibitor Theater
2:15 pm Simultaneous Plenary Sessions 1 – Choose from 2
3:05 pm The American Journal of Gastroenterology Lecture
Introduced by: Brian E. Lacy, MD, PhD, FACG, and Brennan M. Spiegel, MD, MSHS, FACG
Presenter: Amy S. Oxentenko, MD, FACG

“Hidden in Plain Sight: Bringing Women into the Scope of Gastroenterology”
Detail the impact of women in the course of history of medicine and gastroenterology.
3:45 pm How to Get Published: ACG Journal Editors' Roundtable
Brian E. Lacy, MD, PhD, FACG, Brennan M. Spiegel, MD, MSHS, FACG, and Brian C. Jacobson, MD, MPH
3:45 pm Break – Visit the Exhibit Hall and Browse Scientific Posters
3:45 pm Exhibitor Theater
4:45 pm Simultaneous Symposia Session 2 – Choose from 3

Symposium 2A: Starting, Switching, and Stopping Therapy in IBD
Moderator: Christina Y. Ha, MD, FACG

  • Starting Therapy in IBD
    Bincy P. Abraham, MD, FACG
    Summarize treatment strategies for initiating therapy in mild and moderate-severe Crohn’s disease and ulcerative colitis.
  • Switching Therapy in IBD
    Raymond K. Cross, MD, MS, FACG
    Decide when to switch within and out of medication class in IBD, including loss of response, immunogenicity, adverse events, and biosimilars.
  • Stopping and De-Escalating Therapy in IBD
    Christina Y. Ha, MD, FACG
    Describe a practical approach to de-escalation and monitoring of IBD therapy.

Symposium 2B: ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Moderator: Brian E. Lacy, MD, PhD, FACG

  • IBS — Making the Diagnosis
    Brian E. Lacy, MD, PhD, FACG
    Discuss the ACG guideline recommendations for diagnostic testing in irritable bowel syndrome.
  • Pharmacotherapy of IBS
    Darren M. Brenner, MD, FACG
    Describe the rationale for ACG guideline recommendations for pharmacologic therapy for irritable bowel syndrome.
  • Non-Pharmacologic Treatment Options for IBS
    Baharak Moshiree, MD, MSc
    Interpret the latest ACG guidelines as they relate to the non-pharmacologic management of IBS patients.

Symposium 2C: Live From Las Vegas, the 9th Annual Endoscopy Video Forum!

Moderators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG
Judges: David J. Hass, MD, FACG; Laith H. Jamil, MD, FACG; Pichamol Jirapinyo, MD, MPH; Shivangi T. Kothari, MD, FACG; Saowanee Ngamruengphong, MD; Kevin E. Woods, MD, MPH

Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.

6:00 pm ACG’s Annual Business Meeting
All Members and Fellows of ACG are invited.
6:30 pm Annual Scientific Meeting Adjourns for the day.